Importance of patient reported outcomes in choice of therapy for mamma patients

Completed

• Conditions: Breastcancer; malignant tumor breast; 10006291; 10006295

• Registration Number: NL-OMON38173
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 650

Inclusion Criteria

- 18 years or older
- Underwent surgery for breastcancer between 9 and 18 months ago

Exclusion Criteria

- Metastatic disease

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>An overview of the more en less important outcomes after treatment of breast<br /><br>cancer in the opinion of patients. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>